Admin No Comments

Elsevier, the global information analytics business specializing in science and health, has named Christopher Larkin to the Chief Technology Officer position overseeing its Health Markets.

Larkin comes to Elsevier from GE, where he was Vice President for GE Digital’s Predix Advanced Analytics and Data Products. Prior to that, Larkin was CTO for GE Healthcare, where he led teams working on precision and regenerative medicine solutions in the healthcare and life sciences marketplace through predictive analytics, machine learning, image analytics, and big data for genetic and oncology applications.

“The acceleration of personalized medicine will depend on our ability to rapidly transform scientific content into actionable insight,” Larkin said. “The delivery of insight is how our healthcare provider community will maximize patient outcomes. I believe Elsevier is positioned for leadership in this transformation and am truly excited to join the team.”

Elsevier’s Health Markets includes Clinical Solutions and Education. The Clinical Solutions group provides reference and workflow solutions for physicians and other medical professionals, from clinical decision support and patient engagement to competency management and academic education. The Education group provides institutions, educators and students with content and innovative teaching, and learning technology that delivers data and analytics for improving student and program outcomes.

“Our solutions for clinicians and medical researchers increasingly are driven by AI technologies, and we’re bringing together a talented team to help us develop and deliver these solutions to the market,” said Dan Olley, Executive Vice President and Chief Technology Officer for Elsevier, to whom Larkin will report. “Chris brings a wealth of business experience and deep technology knowledge to Health Markets. We’re pleased to welcome Chris to our growing team.”

Larkin has an MS in Industrial Engineering and Operations Research from the University of Massachusetts at Amherst. He will be based in Elsevier’s Philadelphia office.